Module 18 2021

07/02/2021

MDs incorporating ancillary medicinal substances  Regulation of medical devices ● NB / CA consultation ● Clinical trial notifications (CTNs) ● Overseeing notified bodies – CE marking – NBOp ● Post market surveillance/inspection ● Enforcement and prosecution

The Organisation for Professionals in Regulatory Affairs

25

EMA consultations

The Organisation for Professionals in Regulatory Affairs

26

13